| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 08/19/1999 | CA2317451A1 Antagonists of gonadotropin releasing hormone |
| 08/18/1999 | EP0935466A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/17/1999 | US5939432 Thiophenes useful for modulating the adenosine receptor |
| 08/17/1999 | US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 08/17/1999 | US5939386 Growth hormone (gh) or somatotropin, secreted by the pituitary gland constitute a family of hormones |
| 08/12/1999 | WO1999031260A3 Regulatory sequences involved in pancreas-specific gene expression |
| 08/11/1999 | EP0934334A1 8(9)-dehydroestradiol derivatives |
| 08/11/1999 | EP0934299A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934298A1 NOVEL (+)-ENANTIOMERS OF $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES |
| 08/11/1999 | EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same |
| 08/11/1999 | CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease |
| 08/11/1999 | CN1225273A Health-care traditional Chinese medicine, and method for preparing same |
| 08/10/1999 | US5936089 Dipeptides which promote release of growth hormone |
| 08/10/1999 | US5936064 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
| 08/10/1999 | US5935602 Dosage forms of risedronate |
| 08/04/1999 | EP0933354A1 Calcium receptor-active compounds |
| 08/04/1999 | EP0695309B1 Oxytocin antagonist |
| 08/04/1999 | EP0575490B1 GnRH ANALOGS |
| 08/04/1999 | CN1225083A Calcium receptor-active compounds |
| 08/04/1999 | CN1224725A Somatotropin releasing peptide and its application |
| 08/03/1999 | US5932598 Prodrugs of benzenesulfonamide-containing COX-2 inhibitors |
| 08/03/1999 | US5932595 Antiarthritic agent; multiple sclerosis; osteoporosis; respiratory system disorders; skin disorders; antiulcer agent |
| 08/03/1999 | US5932560 Treatment of conditions and disease |
| 07/29/1999 | WO1999037604A2 Dialkyl ureas as calcitonin mimetics |
| 07/29/1999 | WO1999021617A3 Allosteric adenosine receptor modulators |
| 07/29/1999 | CA2284864A1 Dialkyl ureas as calcitonin mimetics |
| 07/28/1999 | EP0931786A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 07/28/1999 | EP0930879A2 Use of calcium dobesilate for the manufacture of a medicament for the treatment of embryonic retardation |
| 07/27/1999 | US5929048 Treatment of conditions and disease |
| 07/27/1999 | US5929028 Liquid gonadotropin containing formulations |
| 07/22/1999 | WO1999024042A3 Stable antiandrogenic gel composition |
| 07/22/1999 | WO1999017712A3 Tightening and/or reducing the size of body parts containing fat cells |
| 07/21/1999 | EP0929218A2 P2y receptor antagonists |
| 07/21/1999 | EP0929216A1 Method of treating post menopausal diseases, including osteoporosis |
| 07/21/1999 | EP0765327B1 Pyrazolo and pyrrolopyridines |
| 07/21/1999 | EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES |
| 07/21/1999 | CN1044234C Substituted phenylimidazolidines, their preparation process, their use as medicaments and the pharmaceutical compositions containing them |
| 07/20/1999 | US5925730 Decapeptide gonadotrophin releasing hormone antagonists; for antifertility agents especially for males; precocious puberty; dysmenorrhea; antitumor/anticarcinogenic agents; endometriosis |
| 07/20/1999 | US5925619 Formulation for peptide release |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035161A1 Process for preparing carboxamido-4-azasteroids |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2278487A1 Process for preparing carboxamido-4-azasteroids |
| 07/14/1999 | EP0928609A2 Use of sulphamate derivatives as steroid sulphatase inhibitors |
| 07/14/1999 | CN1222383A Chinese medicine for curing female endocrinopathy and its preparation |
| 07/13/1999 | US5922875 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 07/13/1999 | US5922770 Novel compounds that stimulate the release of growth hormone from the pituitary |
| 07/13/1999 | US5922747 Comprising testosterone reductase used for treatment of acne, alopacia, skin and glandular disorders, prostatic hypertropy, |
| 07/13/1999 | US5922700 Kit for drug delivery of steroids |
| 07/13/1999 | US5922675 A mixture of fatty acid amidated polypeptides and regular insulin for treating diabetes, use an extended duration of action |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033855A1 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS |
| 07/08/1999 | WO1999033831A1 Nitrogen-containing heterocyclic compounds, their production and use |
| 07/08/1999 | WO1999033828A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/08/1999 | CA2316444A1 11.beta.-halogen-7.alpha.-substituted estratrienes, process for the production of pharmaceutical preparations that contain these 11.beta.-halogen-7.alpha.-substituted estratrienesas well as their use for the production of pharmaceutical agents |
| 07/08/1999 | CA2315055A1 Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 07/08/1999 | CA2300479A1 Nitrogen-containing heterocyclic compounds, their production and use |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927040A1 Process to obtain oestrogens from mare's urine |
| 07/07/1999 | EP0927029A1 Novel methods |
| 07/07/1999 | EP0927028A1 Use of sibutramine analogues to prevent the development of diabetes |
| 07/06/1999 | US5919795 Atherosclerosis therapy |
| 07/06/1999 | US5919477 Two jutaposed devices |
| 07/01/1999 | WO1999032482A1 Hypoglycemic imidazoline compounds |
| 07/01/1999 | WO1999032112A1 Method for treating diabetes |
| 07/01/1999 | CA2315226A1 Hypoglycemic imidazoline compounds |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0926148A1 Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925071A1 Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions |
| 06/30/1999 | EP0925069A1 Means for treating prostate hypertrophy and prostate cancer |
| 06/30/1999 | CN1221417A Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/30/1999 | CN1221410A Novel substituted 2,4-thiazolidine diketone derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 06/30/1999 | CN1221347A Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 06/29/1999 | CA1340616C Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031260A2 Regulatory sequences involved in pancreas-specific gene expression |
| 06/24/1999 | WO1999030708A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 06/24/1999 | CA2315256A1 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | CA2312347A1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/23/1999 | EP0924209A1 Hypoglycemic imidazoline compounds |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/23/1999 | EP0923539A1 Compounds with growth hormone releasing properties |
| 06/22/1999 | US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue |
| 06/22/1999 | CA2151674C Methods of administering crf antagonists |
| 06/20/1999 | CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease |
| 06/20/1999 | CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases |
| 06/17/1999 | WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 06/16/1999 | EP0922770A2 A microbiological process for the transformation of 17beta-carboxy substituted 3-oxo-4-azasteroids and the use of such products as inhibitors of the enzyme 5alpha-reductase |
| 06/16/1999 | EP0922446A1 Solution-phase site-specific preparation of GRF-PEG conjugates |
| 06/16/1999 | EP0922100A2 Secreted proteins and polynucleotides encoding them |
| 06/16/1999 | EP0921798A1 Novel treatment of leptine resistance |
| 06/16/1999 | EP0921786A1 Nasal administration of desmopressin |